Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

[1]  Robert T. Chen,et al.  The development of standardized case definitions and guidelines for adverse events following immunization. , 2007, Vaccine.

[2]  朱丽琳,et al.  Anaphylaxis , 2006 .

[3]  D. Hepner,et al.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. , 2006, The Journal of allergy and clinical immunology.

[4]  D. Hepner,et al.  Symposium on the definition and management of anaphylaxis: summary report. , 2005, The Journal of allergy and clinical immunology.

[5]  P. Kam,et al.  Mast cell tryptase: a review of its physiology and clinical significance , 2004, Anaesthesia.

[6]  Thomas Bieber,et al.  Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. , 2004, The Journal of allergy and clinical immunology.

[7]  Arvind Madaan,et al.  Vaccine allergy: diagnosis and management. , 2003, Immunology and allergy clinics of North America.

[8]  M. Fredette,et al.  Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Davis,et al.  Risk of anaphylaxis after vaccination of children and adolescents. , 2003, Pediatrics.

[10]  H. Sampson.  Anaphylaxis and emergency treatment. , 2003, Pediatrics.

[11]  D. Skowronski,et al.  Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  P. Scheinmann,et al.  Vaccine allergy and pseudo-allergy. , 2003, European journal of dermatology : EJD.

[13]  Robert T. Chen,et al.  Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. , 2002, Pediatrics.

[14]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[15]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.

[16]  M. Paunio,et al.  Allergic reactions to measles-mumps-rubella vaccination. , 2001, Pediatrics.

[17]  H. Peltola,et al.  Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. , 2000, The Pediatric infectious disease journal.

[18]  D. Greenes,et al.  Biphasic Anaphylactic Reactions in Pediatrics , 2000, Pediatrics.

[19]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[20]  R. Pumphrey,et al.  Postmortem findings after fatal anaphylactic reactions , 2000, Journal of clinical pathology.

[21]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[22]  G. Mootrey,et al.  Anaphylaxis from yellow fever vaccine. , 1999, The Journal of allergy and clinical immunology.

[23]  Pamela W Ewan,et al.  ABC of allergies: Anaphylaxis , 1998 .

[24]  C. Caffarelli,et al.  Anaphylaxis in Children: Clinical and Allergologic Features , 1998, Pediatrics.

[25]  P. Anderson.  Clinical Immunology: Principles and Practice , 1996 .

[26]  R. Pless,et al.  Adverse events temporally associated with meningococcal vaccines. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  P. Roberson,et al.  Safe administration of the measles vaccine to children allergic to eggs. , 1995, The New England journal of medicine.

[28]  J. S. Brown,et al.  Biphasic systemic anaphylaxis: an inpatient and outpatient study. , 1994, The Journal of allergy and clinical immunology.

[29]  A. Carter,et al.  Adverse events temporally associated with immunizing agents--1989 report. , 1991, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.

[30]  L. Schwartz,et al.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. , 1989, The Journal of clinical investigation.

[31]  J. Milstien,et al.  Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: an analysis after 1 year of marketing. , 1987, Pediatrics.

[32]  T. Sullivan,et al.  Biphasic and protracted anaphylaxis. , 1986, The Journal of allergy and clinical immunology.

[33]  R. Jacobs,et al.  Adverse reactions to tetanus toxoid. , 1982, JAMA.

[34]  Smith Re.  Allergic reactions to immunization materials in children and approach to diagnosis. , 1965 .